Date	Name	Title	Type	Shares Traded	Price Range
Mar 3, 2008	topper james n	Director	Buy	18,426	9.83 - 9825.00
Jul 27, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	17,800	11.26 - 11.50
Jul 27, 2007	topper james n	Director	Buy	17,800	11.26 - 11.50
Jun 5, 2007	barkas alexander e	Director	Option Execute	15,119	6.38
Jun 5, 2007	prospect venture partners ii lp	Beneficial Owner (10% or more)	Option Execute	15,119	6.38
Jun 5, 2007	barris peter j	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	kramlich c richard	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	new enterprise associates 11 lp	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	newhall charles w iii	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	perry mark w	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jul 15, 2008	licholai gregory p	Officer	Sell	15,000	13.00
Jul 15, 2008	licholai gregory p	Officer	Option Execute	15,000	0.64
Jul 22, 2008	licholai gregory p	Officer	Sell	15,000	15.00
Jul 22, 2008	licholai gregory p	Officer	Option Execute	15,000	0.64
Feb 27, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	14,700	9.65 - 9.94
Feb 27, 2008	topper james n	Director	Buy	14,700	9.65 - 9.94
Jun 29, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	13,900	11.41 - 11.50
Jun 29, 2007	topper james n	Director	Buy	13,900	11.41 - 11.50
Feb 1, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	13,600	9.75 - 9.93
Feb 1, 2008	topper james n	Director	Buy	13,600	9.75 - 9.93
Showing 81-100 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.